Advanced Biomed Inc. (ADVB)
NASDAQ: ADVB · Real-Time Price · USD
0.7854
-0.0143 (-1.79%)
Jul 16, 2025, 4:00 PM - Market closed
Advanced Biomed Employees
Advanced Biomed had 40 employees as of June 30, 2024. The number of employees did not change compared to the previous year.
Employees
40
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$84,169
Market Cap
17.05M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 40 | 0 | - |
| Jun 30, 2023 | 40 | 2 | 5.26% |
| Jun 30, 2022 | 38 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ADVB News
- 2 months ago - Sonoro Energy, Advanced BioCatalytics, and NexTier Energy Launch Strategic Collaboration to Advance Heavy Oil Recovery from Carbonate Reservoirs in the Middle East - TheNewswire
- 4 months ago - Advanced Biomed Inc. Announces Closing Of US$6.56 Million Initial Public Offering - GlobeNewsWire
- 2 years ago - IPO Update: Advanced Biomed Finalizes $112 Million U.S. IPO Plan - Seeking Alpha
- 2 years ago - Advanced Biomed sets IPO terms, which could value the biotech at up to $625 million - Market Watch
- 2 years ago - Advanced Biomed Begins $150 Million U.S. IPO Rollout - Seeking Alpha
- 2 years ago - Advanced Biomed IPO Registration Document (S-1) - SEC